Madrigal Pharmaceuticals (MDGL) Total Debt (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Madrigal Pharmaceuticals | 14.44 Bn | 14.20 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.13% |
| Dec 31, 2025 | 0.04% |
| Sep 30, 2025 | 187.01% |
| Jun 30, 2025 | 0.31% |
| Mar 31, 2025 | 0.37% |
| Dec 31, 2024 | 0.41% |
| Sep 30, 2024 | 0.41% |
| Jun 30, 2024 | 0.41% |
| Mar 31, 2024 | 0.57% |
| Dec 31, 2023 | 0.66% |
| Sep 30, 2023 | 15.60% |
| Jun 30, 2023 | 18.20% |
| Mar 31, 2023 | 70.35% |
| Dec 31, 2022 | 0.62% |
| Sep 30, 2022 | 0.64% |
| Jun 30, 2016 | -99.57% |
| Mar 31, 2016 | -50.10% |
| Dec 31, 2015 | -33.36% |
| Sep 30, 2015 | -25.00% |
| Jun 30, 2015 | -19.99% |
| Mar 31, 2015 | -16.65% |
| Dec 31, 2014 | -14.26% |
| Sep 30, 2014 | -12.47% |
| Jun 30, 2014 | -11.38% |
| Mar 31, 2014 | -10.70% |
| Dec 31, 2013 | -1.00% |
| Sep 30, 2013 | -0.92% |
| Jun 30, 2013 | -7.26% |
| Mar 31, 2013 | 106.50% |
| Dec 31, 2012 | -13.70% |
| Sep 30, 2012 | -12.03% |
| Jun 30, 2012 | -0.94% |
| Mar 31, 2012 | -0.91% |
| Dec 31, 2011 | -0.86% |
| Sep 30, 2011 | -0.83% |